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ABSTRACT 
DNA ligase IV is an essential protein that functions in DNA non-homologous end-
joining, the major mechanism that rejoins DNA double strand breaks in mammalian 
cells. LIG4 syndrome represents a human disorder caused by mutations in DNA 
ligase IV that lead to impaired but not ablated activity. Five conserved motifs in DNA 
ligases have been previously identified. We previously reported G469E as a 
mutational change in a LIG4 syndrome patient. G469 does not lie in any of the 
previously reported motifs. A sequence comparison between DNA ligases led us to 
identify residues 468-476 of DNA ligase IV as a further conserved motif, designated 
motif Va, present in eukaryotic DNA ligases. We carried out mutational analysis of 
residues within motif Va examining the impact on adenylation, double-stranded 
ligation, and DNA binding. We interpret our results using the DNA ligase I:DNA 
crystal structure. Substitution of the glycine at position 468 with an alanine or 
glutamic acid severely compromises protein activity and stability. Substitution of 
G469 with an alanine or glutamic acid is better tolerated but still impacts upon 
activity and protein stability. These finding suggest that G468 and G469 are important 
for protein stability and provide insight into the hypomorphic nature of the G469E 
mutation identified in a LIG4 syndrome patient. In contrast, residues 470, 473 and 
476 within motif Va can be changed to alanine residues without any impact on DNA 
binding or adenylation activity. Importantly however, such mutational changes do 
impact upon double stranded ligation activity. Considered in light of the DNA ligase 
I:DNA crystal structure, our findings suggests that motif Va  functions as part of a 
molecular pincer that maintains the DNA in a conformation that is required for 
ligation. 
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Introduction 
DNA non-homologous end-joining (NHEJ) is the major mechanism for the rejoining 
of DNA double strand breaks (DSBs) in mammalian cells [1]. Five proteins have been 
identified that function in NHEJ. The heterodimeric protein, Ku, binds to double 
stranded DNA ends, recruits and activates the catalytic subunit of the DNA-dependent 
protein kinase, DNA-PKcs. Together this complex constitutes the DNA-dependent 
protein kinase (DNA-PK). DNA-PK then recruits Xrcc4 and DNA ligase IV, which 
tightly co-associate. DNA ligase IV carries out the final rejoining step of NHEJ. In 
addition to playing a major role in the rejoining of radiation and endogenously 
induced DSBs, NHEJ also effects the rejoining step during V(D)J recombination [2]. 
Although Xrcc4 and DNA ligase IV are essential in mice, LIG4 syndrome has been 
identified as a human disorder conferred by hypomorphic mutations in DNA ligase IV 
[3-6]. The disorder is associated with clinical radiosensitivity and immunodeficiency, 
consistent with the known functions of DNA ligase IV. LIG4 syndrome patients also 
display developmental delay and microcephaly suggesting that DNA ligase IV plays 
an important role during development. 
DNA ligase IV contains a conserved ligase domain at its N-terminus and a 
tandem BRCT domain at its C-terminus (Fig. 1a) [7]. Interaction with Xrcc4 requires 
the region between the BRCT domains and likely part of the BRCT domain [8,9]. The 
DNA ligase IV/Xrcc4 complex is large and its crystal structure has not yet been 
solved. Structural analysis has relied in part on the use of a range of other ATP-
dependent DNA ligases as model systems [10-15]. The first step of ligation involves 
the formation of a covalent AMP-enzyme intermediate with AMP being attached to 
the enzyme via a highly conserved lysine residue. The second step involves formation 
of a DNA-adenylate complex followed finally by rejoining. All ATP-dependent DNA 
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ligases have a modular structure of two domains, an adenylation domain (AdD or 
Domain 1) and an oligo-binding domain (OBD or Domain 2) [12]. Six conserved 
motifs, designated motifs I, III, IIIa, IV, V and VI, have been identified among 
covalent nucleotide transferases, of which 5 are found in the AdD (Fig. 1a ). Motifs I, 
III, IIIa, IV and V are essential for ATP binding and the auto-adenylation reaction. 
Motif I, encompassing the conserved lysine residue, forms the active site loop of the 
enzyme and constitutes part of the ATP binding pocket. Based on the crystal 
structures of a number of DNA ligase complexes, it has been proposed that ligases 
undergo profound conformational changes upon ATP binding and/or DNA binding 
[10,12,13,16,17]. This is exemplified by the rotation of the OBD.  Motif VI lies 
within the OBD, distant from the active site on AdD [10]. However, upon ATP-
binding this face of OBD moves towards the active site and residues, including those 
from motif VI, participate in the adenylation reaction [13,14,16,17]. Subsequently, the 
OBD moves away from the active site and swivels around placing motif VI far from 
the AdD, orientating the DNA-binding surface of OBD towards the now adenylated 
AdD [12,13,16,17]. This switching is essential for the catalytic cycle as it most likely 
prevents the formation of non-productive complexes between non-adenylated ligase 
and unnicked/unbroken DNA. 
The larger eukaryotic ligases, such as LigI and LigIV, also possess an 
additional N-terminal DNA-binding domain (DBD) that is required for efficient 
ligation (Fig. 1c) and enables these ligases to encircle DNA [17]. An equivalent helix-
hairpin-helix domain is also present in the bacterial NAD-dependent ligases [13,18].  
The toroidal structure of LigI maintains the nicked DNA in a distorted conformation 
and locates the catalytic domain over the site of the nick prior to ligation [17].   
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 Since DNA ligase IV is essential, the mutations identified in LIG4 syndrome 
are hypomorphic, that is, they confer residual activity. The analysis of the impact of 
such mutations is important to help evaluate the clinical impact and potentially to help 
direct patient care. Additionally, such mutations have the potential to provide novel 
insight into domains or motifs important for function. In one LIG4 syndrome patient 
an arginine was mutated to histidine within motif 1 (R278H) close to the active site 
lysine residue [19,20]. More recently, another mutational change (G469E) was 
identified [5]. Although this mutation lies adjacent to a conserved residue (G468), it 
lies outside of the six core motifs and, when first identified, we questioned whether it 
would alter the activity of the enzyme [21]. Our initial studies demonstrated, however, 
that it was a mutational change that impacted upon function [5]. A sequence 
comparison between DNA ligases strongly suggests that residues 468-476 represent a 
further conserved motif present in eukaryotic DNA ligases, which we have designated 
motif Va (Fig. 1b). The recently reported structure of DNA ligase I also provides 
evidence that this region might be important for function (Pascal, 2004 #10951). 
Here, we have undertaken, a mutational analysis of residues within motif Va to 
determine whether it was also important for function in DNA ligase IV. Mutational 
change of either residue G469 or G468 markedly reduced both adenylation and 
ligation activity. Since the mutant proteins were difficult to express our findings 
suggest that these two residues are important for protein stability and we consider this 
in the light of the DNA ligase I/DNA structure. Additionally, we found that residues 
470-476 do not affect either DNA binding or adenylation activity but significantly 
impair double-stranded ligation activity. We present a model that these residues act, 
along with another conserved structural motif, as a pincer to facilitate the 
conformational change of the DNA to enhance catalaysis.  
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Materials and Methods  
Expression of wild type and mutant Xrcc4/DNA ligase IV complexes in insect 
cells.  
The pFastBac vector (Invitrogen) expressing wild type histidine tagged human DNA 
ligase IV was as previously described.[20,22] Human Xrcc4 was obtained from pCI-
neo-Xrcc4 by digestion with EcoRI and NotI, and inserted into the multiple cloning 
site of pFasBac Dual vector (Invitrogen) generating pFastBacDual-Xrcc4. 
Transcription was under the control of the polyhedron promoter. pFastBac vectors 
expressing histidine tagged DNA ligase IV mutants were generated by site directed 
mutagenesis. The DNA ligase IV coding sequence of the wild type and mutant 
constructs was sequenced to verify the presence of the mutation and the absence of 
non-specific mutations. The two recombinant baculoviruses expressing histidine 
tagged wild type or mutant DNA ligase IV and untagged Xrcc4 were co-expressed 
using the Bac-toBac Baculovirus expression system (Gibco). 
 
Purification of WT and mutant DNA Ligase IV-XRCC4 Complexes. 
The Sf9 (Spodoptera frugiperda ovary) cells were maintained at 27°C in SF-900 II 
medium (Invitrogen). Sf9 cells, at 1.5x106 cells/ml density, were co-infected with 
DNA ligase IV and Xrcc4 baculoviruses at the same multiplicity of infection. Ninety-
six hours after infection, cells were harvested by centrifugation, resuspended in lysis 
buffer (50 mM Tris-HCl, pH 8.0, 0.5 mM  β-mercaptoethanol, 1% Nonidet P-40) 
supplemented with protease inhibitors (Roche Molecular Biochemicals) and incubated 
for 10 minutes at 4°C. 10 ml of lysis buffer was used per 100 ml of cell culture. The 
lysate was cleared by centrifugation and incubated with TALON metal affinity resin 
(Clontech) for 2 h at 4°C. The resin was washed with lysis buffer, then buffer (20 mM 
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Tris-HCl, pH 8, 0.5 mM β-mercaptoethanol, 12.5 mM imidazole) containing 500 mM 
NaCl (three washes) and finally buffer containing 100 mM NaCl (two washes). The 
histidine-tagged ligase IV in complex with untagged Xrcc4 was eluted in E buffer (20 
mM Tris-HCl, pH 8.0, 100 mM NaCl, 5 mM β-mercaptoethanol, 100 mM imidazole). 
Purified complexes were dialyzed and concentrated in buffer (20 mM Tris-HCl pH 
8.0, 50 mM NaCl ) on 0.5 ml Vivaspin columns (10 kDa cut-off size). Aliquots of the 
purified complexes were snap-frozen in liquid nitrogen and stored at -80°C in the 
presence of 10% glycerol. The purity of the preparation was verified by SDS-
polyacrylamide gel stained with Colloidal Coomassie blue G-250 (Sigma). 
The concentration of the ligase IV/Xrcc4 complex was determined by UV 
absorption measurements using an extinction coefficient at 280 nm of 121,330 M-1 
cm-1 estimated from the amino acid sequence (ProtParam, available at 
www.expasy.ch). The value obtained was confirmed by comparing the Coomassie 
Blue staining of the complexes with that of a known quantity of BSA after SDS-
PAGE. The concentration of the G468E and G469E ligase IV/Xrcc4 complexes was 
only quantified by Coomassie Blue staining relative to wild type complexes. All other 
mutant complexes were quantified by both UV absorption and quantitative Coomassie 
Blue Staining.  
 
Adenylation Assay  
Wild type and mutant protein complexes were pretreated in buffer (20 mM Tris-HCl , 
pH 8.0, 50 mM NaCl ) containing 5 mM disodium pyrophosphate for 15 min at room 
temperature. A Vivaspin 0.5 ml column (Sartorius) was used to remove 
pyrophosphate. Varying amounts of wild type and mutant protein complexes were 
incubated with [α-32P]ATP (0.5 µCi, Amersham) in adenylation buffer (60mM Tris-
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HCl, pH 8.0, 10 mM MgCl2, 5 mM dithiothreitol) in 10 µl of reaction volume. Each 
reaction was incubated for 10 minutes at room temperature. Reactions were stopped 
by the addition of 1 volume of 2X standard SDS-polyacrylamide gel electrophoresis 
loading buffer. The samples were boiled for 5 min and run on a 9% SDS-
polyacrylamide gel. Fixed and dried gels were analyzed and quantified using a 
STORM PhosphorImager (Molecular Dynamics). 
 
Double-Stranded ligation assay. 
 A 442bp ds DNA fragment with 4bp overhangs at each end was produced from the 
Bluescript plasmid (Stratagene) following digestion with PstI and AflIII (New 
England Biolabs) and purification by electrophoresis using a 0.8% agarose gel. 
Following gel-extraction with Qiaquick DNA extraction kit (Qiagen), the 442bp 
substrate was treated with CIP and was 5’ end-labelled with [γ-32P] ATP. 
The indicated amounts of protein complexes were incubated for 30 minutes in 30 µl 
of reaction mixture (50 mM triethanolamine, pH 7.5, 2 mM Mg(OAc)2, 2 mM 
dithiothreitol, 0.1 mg/ml bovine serum albumin, 12% polyethylene glycol) with 20 ng 
of labelled DNA fragment. After incubation, the reactions were stopped by the 
addition of 1.5 µl of 10% SDS.  Following deproteinization using the Qiaquick 
purification columns (Qiagen), the DNA was eluted in 30 µl of water. 15 µl of DNA 
were added to 1 volume of 2X standard DNA loading buffer, heated to 65°C for 5  
minutes then cooled rapidly to 4 °C  on ice. The DNA was electrophoresed on a 0.8% 
agarose gel. Dried gels were analyzed and quantified using Cyclon Storage Phosphor 
System (Packard). 
 
Electrophoretic Mobility Shift Assays 
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For electrophoretic mobility shift assays  (EMSA) studies, the DNA substrate was a 
54bp DNA fragment with 4bp overhangs prepared by annealing two complementary 
synthetic oligonucleotides (54-mer). One 54-mer was labelled at the 5’end prior to 
annealing using T4-PNK and [γ -32P] ATP. LX was incubated with the DNA (15 
fmol) in 20 µl of reaction mixture (10mM triethanolamine pH 7.5, 0.5 mM 
dithiothreitol, 0.1 mg/ml bovine serum albumin) at room temperature for 20 minutes. 
Loading buffer was added (20% Ficoll, 0.4% xylene cyanol), and the samples were 
subjected to 8% PAGE in 0.5 x TAE buffer (20 mM Tris acetate, 0.5 mM EDTA), pH 
8.1 at 4°C. Dried gels were analyzed using Cyclon Storage Phosphor System 
(Packard). 
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Results 
Identification of motif Va in DNA ligases 
G469E is a mutational change identified in a LIG4 syndrome patient. Further 
examination of the amino acid sequence in the vicinity revealed the presence of a 
motif well conserved between DNA ligases I, III and IV and less stringently 
conserved in more distantly related DNA ligases (Fig. 1a).  G468 is highly conserved 
in all ATP-dependent ligases [21].  The tyrosine, glycine, glycine and arginine 
residues at positions 3, 5, 7 and 9 are also well conserved (Fig. 1b).  Examination of 
the crystal structure of DNA ligase I revealed that this motif, designated motif Va 
(Fig. 1b), lies in a loop located on the surface of the OBD (Fig. 1c). Following DNA 
binding, motif Va makes close contact with the DNA (Fig. 1c). This motif may, 
therefore, be important for transactions of DNA ligase IV with DNA during catalysis. 
To examine this further, we created DNA ligase IV cDNAs expressing mutational 
changes as shown in Fig. 2a, expressed the mutant proteins in baculovirus (Fig. 2b) 
and examined their activity using in vitro assays for adenylation, double stranded 
ligation, and DNA binding. 
 
Mutations at residues 470-476 do not impact upon adenylate complex formation. 
Previously, we observed that Xrcc4 can be stably expressed and solubilised in insect 
cells in the absence of DNA ligase IV but not vice versa. Xrcc4 stimulates DNA 
ligase IV activity. Therefore, to ensure that we monitor the activity of DNA ligase IV 
complexes, we designed baculovirus constructs expressing histidine-tagged DNA 
ligase IV and non-tagged Xrcc4. After co-expression of wild type (WT) or mutant 
proteins in insect cells, we purified ligase IV/Xrcc4 complexes exploiting the histidine 
tag on DNA ligase IV. All complexes contained similar molar ratios of DNA ligase 
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IV:Xrcc4 demonstrating, as predicted, that mutations in motif Va do not impair 
interaction with Xrcc4 (Fig. 2). The WT DNA ligase/Xrcc4 complex and mutant 
Y470A, K473A, and R476A ligase IV/Xrcc4 complexes were expressed at similar 
levels whereas expression of the G468A and G469A DNA ligase IV/Xrcc4 mutant 
complexes was routinely slightly lower. The G468E and G469E DNA ligase 
IV/Xrcc4 mutant complexes were poorly expressed and had higher levels of non-
specific bands, many of which represent breakdown products, relative to the more 
readily expressed proteins. Similar relative levels of mutant complexes were 
employed in the assays described below (see Materials and Methods). For the G468E 
and G469E complexes, quantification was assessed by Coomassie staining (as shown 
in Fig. 2). Insect cell expressed DNA ligase IV/Xrcc4 complexes are pre-adenylated. 
We, therefore, monitored the ability of the mutant ligase IV/Xrcc4 to form adenylate 
complexes following treatment with inorganic pyrophosphate (PPi) to generate non-
adenylated complexes. Mutation of either G468 or G469 to glutamic acid completely 
abolished adenylate complex formation. Changing either residue to alanine also 
significantly impaired adenylate complex formation, although residual activity was 
readily detectable with the G469A mutant complex and at high protein concentration 
with the G468A mutant protein. In stark contrast, Y470A, K473A and R476A mutant 
complexes were proficient in adenylate complex formation (Fig. 3).  
 These findings suggest that a glycine at positions 468 and 469 is required for 
adenylate complex formation whereas the remaining residues in motif Va do not play 
critical roles in DNA ligase IV adenylate complex formation. 
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Mutational changes within motif Va impact upon DNA ligase IV double-
stranded ligation activity 
The same mutant proteins were examined for double-stranded (ds) ligation activity 
using a 442 bp double stranded DNA fragment with 4 bp overhangs as a substrate. 
Since adenylation is required before ligation can ensue, we used insect cell expressed 
complexes without pyrophosphate treatment to monitor ds ligation in the absence of 
ATP. The G468E and G469E mutant complexes had little or no detectable ligation 
activity (Fig. 4). Surprisingly, G469A despite having significantly impaired 
adenylation activity, showed normal ligation activity (see below). The ds ligation 
activity of the remaining mutant complexes, despite being competent for auto-
adenylation, were significantly impaired although all proteins retained residual 
activity.  Together these findings provide evidence that motif Va is required for 
efficient end-joining. 
The observation that G469A has normal ligation activity despite reduced 
adenylation activity is most likely explained by the fact that DNA ligase IV/Xrcc4 
complexes expressed in insect cell are pre-adenylated. In support of this we have 
observed that adenylation activity is only detectable after treatment with PPi 
suggesting that the majority of the DNA ligase IV/Xrcc4 complexes expressed in 
insect cells are pre-adenylated [22] (data not shown). Additionally, we have found 
that non-adenylatable DNA ligase IV complexes are expressed at low levels in insect 
cells. It seems likely, therefore, that pre-adenylated DNA ligase IV/Xrcc4 complexes 
have enhanced stability relative to non-adenylated complexes and accumulate in 
insect cells. Since none of the mutant complexes showed any adenylation activity in 
the absence of PPi treatment (data not shown), we consider it likely that even mutant 
complexes with low adenylation activity in vitro, accumulate as adenylate complexes 
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in insect cells [20]. G469A may, therefore, be expressed as an adenylated complex 
and be efficient for ligation despite showing impaired in vitro adenylation activity. 
 
Motif Va is dispensable for DNA binding 
To determine if the diminished ligation activity of the mutant complexes could be 
attributed to impaired DNA binding capacity, we used a 54 bp ds DNA fragment in 
electrophoretic mobility shift assays (EMSA) to examine the ability of the motif Va 
mutant proteins to bind to ds DNA. It has been shown previously that WT DNA ligase 
IV/Xrcc4 complex is able to bind efficiently to a DNA fragment of 54bp length [22]. 
We observed that Y470A, R476A and K473A mutant complexes were proficient for 
DNA binding (Fig. 5). Mutant complexes involving G468 and G469 were not 
analysed in this assay due to difficulties in obtaining sufficiently concentrated protein 
for analysis.  
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Discussion 
Previously, we reported the identification of a mutation, G469E, in a LIG4 syndrome 
patient which severely impacts upon DNA ligase IV function [5]. Closer examination 
of the sequence in the vicinity of G469 revealed a motif, designated Va, that is well 
conserved between DNA ligases (Fig 1b).  Mutational analysis of residues within 
motif Va highlights an important role in ligation.  G468 represents a highly conserved 
residue, as noted previously [21] which, we show, is required for adenylate complex 
formation and for catalysis.  In contrast, residues 470, 473 and 476 which lie within 
the loop region encompassing motif Va are dispensable for adenylate complex 
formation and for DNA binding but are required for efficient DNA ligation. During 
the course of this work, the crystal structure of the Ligase I:DNA complex was 
reported [17], enabling us to directly evaluate the observed mutational effects at the 
molecular level. 
 G468 is buried within the OBD at a position of close packing between β sheets 
(Fig. 6a). Glycine is an atypical amino acid lacking a side-chain. It is likely that 
substitution of this residue by other amino acids would severely compromise the 
stability of the OBD.  Indeed, substitution of a glutamic acid, which has a large side-
chain resulted in a protein that appeared to be poorly expressed, likely due to impaired 
stability. Substitution of the slightly smaller alanine was slightly better tolerated but 
protein expression was still low. The mutant proteins showed little functional activity 
either for adenylation or ligation activities consistent with a significant impact on 
conformation. G469, which is slightly less buried in the OBD, also appears to be 
important for protein conformation. Significantly, G469A is better tolerated than other 
substitutions at the 468/469 residues and yields a protein with measurable residual 
 15 
adenylation activity. This is consistent with the less stringent conservation of this 
residue, and indeed, DNA ligase I has an alanine at this site. The near normal ligation 
activity of G469A suggests that once adenylate complex formation occurs, protein 
stability may be enhanced and the protein can carry out double-stranded ligation 
efficiently. The substitution by a residue with a bulkier side-chain (glutamic acid) is 
less well tolerated at this position. Together, this analysis suggests that G469E 
generates a protein with significant reduced conformational stability but retaining 
some residual activity providing an explanation for the viability but significant 
clinical features of the patient. 
In contrast to G468 and G469, which are buried (Fig. 6a), residues 470-476 
are equivalent to the surface loop L12 present in the crystal structure of the LigI 
complex (Fig. 6b) [17]. The OBD of DNA ligases adopts at least two distinct 
orientations during the catalytic cycle. In the adenylation step, the face of the ODB 
which contains motif VI swivels towards the AdD following ATP binding formation, 
acting as a “lid” over the active site, with a number of OBD residues directly 
participating in the adenylation reaction. In the DNA binding/ligation step, the OBD 
lid opens up (following adenylation) and the domain pivots around, orienting the 
DNA binding face including motif Va towards the active site, positioning motif VI 
away from the AdD.  The OBD of LigI binds directly to DNA [17] interacting with 
the minor groove adjacent to the nicked DNA (Fig. 6b). Pascal et al. have reported 
that the OBD alters the curvature of the DNA backbone, conferring an A-form 
conformation (with an expanded minor groove) on the DNA upstream of the nick and 
maintaining a B-form on the downstream side [17].  A number of regions of LigI are 
critical for preserving the B-type DNA conformation including the loops L12, L45 
and α-helix S.  Surface loop L12 (motif Va) binds to the template strand of DNA 
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(Fig. 6b), making direct contacts via a number of residues, including Arg771 (R476 in 
Lig IV) that extends from L12 into the minor groove (Fig. 6b). Our findings reveal 
that residues in the loop region of motif Va do not impact upon adenylation but are 
required for double-strand ligation activity.  Taken together with the crystal structure 
of Lig I, we suggest that the Motif Va loop functions in conjunction with helix S that 
binds to the opposite strand, as a molecular pincer that senses the dimensions of the 
minor groove (Fig. 6b) and actively maintains the B-form that is essential for efficient 
ligation. Consistent with this model, it has been shown that the presence of an A-form 
structure downstream of a nick severely affects ligation efficiency [17,23,24]. 
Although motif Va may be important for modulating the conformation of the DNA, it 
does not appear to be critical for DNA binding, which is likely due to the fact that the 
DNA makes many contacts with DNA ligase IV involving all three domains [17]. 
Interestingly, a mutation A771W in DNA ligase I has been described in a patient [25]. 
A771 lies within the equivalent motif in ligase I. This mutation does not affect 
adenylate complex formation but does affect nick ligation consistent with our model 
[26]. Notably, mice expressing this mutation exhibit an increased predisposition to 
cancer [27].  Interestingly, although DNA ligases have different substrate specificities 
and DNA ligase III and IV can rejoin DNA/RNA substrates in contrast to DNA ligase 
I, motif Va appears conserved between all DNA ligases, suggesting a role distinct 
from substrate specificity. Our findings suggest that a role in promoting DNA 
conformation may be a conserved function of motif Va although differences in this 
region between ligases might relate to substrate specificity.  
In conclusion, our analysis provides insight into the impact of a mutational 
change observed in a LIG4 syndrome patient suggesting that G469E impacts upon 
protein conformation and/or stability in a manner conferring residual but impaired 
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function. We also demonstrate that residues 470-476 are important for efficient 
double-stranded ligation whilst being dispensable for adenylation and DNA binding. 
We discuss our results in light of the Ligase I:DNA crystal structure and suggest that 
Motif Va plays an important role in promoting conformational changes of the DNA 
that facilitate efficient catalysis. 
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 Figures 
Figure 1. Sequence and structure of DNA ligase motif Va. 
a) The primary domain structure of DNA ligase IV highlighting the positions of the 
conserved catalytic motifs and the newly identified motif Va. 
b) Sequence conservation of motif Va. G469E is the mutational change identified in a 
LIG4 syndrome patient. 
c) The crystal structure of human DNA ligase I:DNA complex shows that motif Va 
forms a loop-like structure (blue) on the surface of the Oligo-Binding domain (OB; 
yellow) and this motif makes direct contact with the DNA (grey). The three conserved 
domains present in mammalian ligases are also highlighted.  
 
Figure 2. Mutational changes studied and expression of wild type and mutant DNA 
ligase IV/Xrcc4 complexes in insect cells. 
a) Position of mutational changes studied. 
b) Coomassie Colloidal Blue staining of dialyzed and concentrated wild type and 
mutant DNA ligase IV/Xrcc4 complexes purified from baculovirus-infected insect 
cells. Values given are in µg of protein. Molecular mass standards (in kilodaltons) are 
shown on the left.  
 
Figure 3. Adenylation activity is impaired in G468 and G469 mutant complexes. 
a) The wild type and the mutant DNA ligase IV/Xrcc4 complexes shown in Figure 2 
were examined for adenylate complex formation following treatment with 
pyrophosphate and incubation with [α-32P] ATP. After separation by SDS-PAGE, 
labelled ligase-AMP adducts migrated as a single band and were detected by 
autoradiography. G468E and G469E mutant complexes had no detectable adenylation 
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activity. Activity was significantly impaired but not ablated in G468A and G469A 
mutant complexes. Nearly normal adenylation activity was observed with complexes 
carrying mutations within the motif Va loop. Values given are ng of protein. The 
amount of G468E and G469E mutants DNA ligase IV/Xrcc4 complexes used in the 
reactions was assessed after Coomassie blue staining to give levels equivalent to 100, 
200, 400 and 800 ng of wild type DNA ligase IV/Xrcc4 complexes. 
b) Quantification of the adenylation activity of wild type and mutant DNA ligase 
IV/Xrcc4 complexes. The specific activities of wild type (WT) and mutant complexes 
were determined from the slopes of the titration curves in the linear range of enzyme 
dependence. The activity values for the mutant complexes were normalized to the 
wild type specific activity. For the G468A the residual adenylation activity of 1000 µg 
of complex was compared to the activity of the same amount of wild type. The results 
represent the mean of three experiments. 
 
 
Figure 4. All motif Va mutant complexes show reduced double-stranded ligation 
activity. 
Double stranded (ds) ligation was assayed using wild type and mutant DNA ligase 
IV/Xrcc4 complexes in the absence of pyrophosphate treatment and ATP.  
a) A DNA substrates of 442 bp length with 4 bp overhangs was incubated with the 
complexes and the ligated DNA multimers of different length were separated in an 
agarose gel. The assay has been carried out using an increasing amount of protein 
(values given are ng of protein). G468E and G469E mutant complexes showed 
dramatically reduced ligation activity. In marked contrast the G469A mutant complex 
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showed nearly normal activity. The remaining complexes showed significantly 
reduced activity. 
b) Quantification of the double stranded ligation activity in wild type and mutant 
DNA ligase IV/Xrcc4 complexes. The percentage of converted subtrate is plotted as a 
function of the quantity of DNA ligase IV/Xrcc4 complexes (logarithmic scale). The 
result represents the mean of three experiments. 
 
Figure 5. Motif Va mutant complexes show normal DNA binding. 
DNA binding of motif Va mutant complexes was assessed using EMSA with a 54bp 
DNA fragment. G468E, G469E, G468A and G469A mutant complexes were not 
assessed for DNA binding due to their diminished purity or lower concentration, 
respectively. The remaining complexes showed nearly normal levels of DNA binding. 
 
Figure 6. Structural aspects of motif Va 
a) The buried position of the most conserved glycine residue (G468, black) of Motif 
Va is shown in the crystal structure of Lig I complex.  
b) The structure of the LigI complex reveals that a number of regions are critical for 
preserving the B-form conformation of the DNA, including the loops L12 (blue), L45 
(not shown) and α-helix S (cyan). L12 (motif Va) binds to the template strand of 
DNA (orange), making direct contacts, including Arg771 (R476 in Lig IV) that 
extends from L12 into the minor groove. 
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